

Shifting Paradigms: Protection Beyond BP Control
Diovan® for Cardiorenal Protection
Abbreviations:
ARB, angiotensin II receptor antagonist; BP, blood pressure; CV, cardiovascular; HF, heart failure; HTN, hypertension; MI, myocardial infarction; UAER, urinary albumin excretion rate.
References:
1. Ruilope, L. Nat Rev Cardiol 2012;9, 267–275. 2. Ruilope LM, et al. Vasc Health Risk Manag. 2007;3(1):1-9. 3. Diovan core data sheet. Novartis Pharma AG. 4. Pfeffer MA et al; for the Valsartan in Acute Myocardial Infarction Trial Investigators. N Engl J Med 2003; 349(20): 1893-1906. 5. Cohn JN et al; for the Valsartan Heart Failure Trial Investigators. N Engl J Med 2001; 345(23): 1667- 1675. 6. Viberti G et al. Circulation 2002; 106(6): 672-678. 7. Julius S et al. Lancet 2004;363(9426): 2022-2031. 8. The NAVIGATOR study group. N Engl J Med. 2010;362: 1477-90. 9. Hollenberg NK et al. J Hypertens 2007; 25(9): 1921-1926.

20 Pasir Panjang Road #10-25/28 Mapletree Business City (West Tower) Singapore 117439
Phone: +65 6722 6010
FOR HEALTHCARE PROFESSIONALS ONLY
APPROVAL CODE
